Brenig Therapeutics, Inc. (Brenig), a clinical-stage biotechnology company advancing small-molecule therapies for neurodegenerative diseases, today announced the initiation of a first-in-human (FIH) clinical study of BT-409, the company’s novel, brain-selective NOD-, LRR-, and pryin domain-containing protein 3 (NLRP3) inflammasome inhibitor. The company also provided an update on the continued clinical advancement of BT-267, its highly […]

Execution-Focused Pilot Builds on AZIO AI’s Expanding AI Infrastructure Pipeline and Validates High-Density Power and Cooling Architecture for Next-Generation Deployments AZIO AI, a next-generation artificial intelligence infrastructure platform, today announced the advancement of a joint immersion-cooled energy infrastructure pilot in collaboration with Envirotech Vehicles (“EVTV”). The execution-focused pilot is designed to validate high-density cooling, power

Build-A-Bear Named to Newsweek and Plant-A Insights Group’s 2026 List of “America’s Greatest Workplaces for Culture, Belonging & Community” Build-A-Bear, the iconic retail experience with a mission of “adding a little more heart to life,” celebrates one of the most meaningful honors a company can receive – recognition rooted not in products or profits, but

Family of Worker Killed in Bristol Health & Rehab Center Explosion Files Lawsuit Cordisco & Saile, LLC has filed a lawsuit on behalf of the family of Muthoni Nduthu, a worker who tragically lost her life in the explosion and fire at the Bristol Health & Rehab Center in Bristol Township, formerly Silver Lake Nursing

Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developers A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO Precision Oncology. The publication provides generic protocols for the analytical validation of tumor-informed ctDNA assays for Molecular Residual Disease (MRD)

Penumbra, Inc. (NYSE: PEN), the world’s leading thrombectomy company, today announced certain unaudited and preliminary financial results for the fourth quarter and full year 2025. Unaudited and Preliminary Financial Highlights: — Fourth quarter 2025 revenue of $383.0 million to $384.8 million, which represents growth of approximately 21.4% to 22.0% compared to the fourth quarter of

Partnership empowers employers offering Aflac to their employees to improve benefit offerings and streamline administration Aflac, a leading provider of supplemental insurance in the U.S.1 today announced it has been named a strategic Workday Wellness partner for supplemental health solutions. Through this engagement, Aflac can integrate its supplemental health products and services with Workday Wellness,

Announces Federal Tax Treatment of 2025 Dividends Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Schedule Main Street Capital Corporation (NYSE: MAIN) (“Main Street” or the “Company”) is pleased to announce its preliminary operating results for the fourth quarter of 2025, the federal tax treatment of its dividends paid in 2025

Agile Consulting Group, sales tax exemption and compliance experts, recently joined the Metals Innovation Initiative (Mi2) as a value provider, further strengthening its commitment to supporting manufacturers across Kentucky. Kentucky has more than 250 metals facilities and a $34 billion metals footprint, according to the Mi2 website, making it a uniquely positioned state to lead

Canadian Solar Inc. (NASDAQ: CSIQ) (the “Company”, or “Canadian Solar”) today announced a decisive victory in litigation proceedings against Maxeon Solar Pte. Ltd. (“Maxeon”) before the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”). In Final Written Decisions, the PTAB ruled in Canadian Solar's favor, holding that all